InvestorsHub Logo
Followers 1171
Posts 169865
Boards Moderated 4
Alias Born 12/20/2003

Re: 02opida post# 616456

Sunday, 04/07/2024 7:57:52 AM

Sunday, April 07, 2024 7:57:52 AM

Post# of 618762
NVS - New Novartis data show early addition of twice-yearly* Leqvio(TM) (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting

History.htm

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.